American College of Clinical Pharmacy
      Search      Cart
         

Diversity & Inclusion

Diversity, Equity, Inclusion, and Accessibility at ACCP

ACCP is dedicated to creating and sustaining a culture of diversity, equity, inclusion, and accessibility (DEIA). A commitment to embrace diversity and inclusion is an ACCP core value. Strategic direction 1.5 of the 2020 ACCP Strategic Plan states that the College will employ practices that embrace DEI to fully achieve its mission.

Beginning in 2020, the ACCP Board of Regents (BOR) has had ongoing complex and in-depth conversations about equity, respect, diversity, and inclusion. In January 2021 the BOR engaged a consulting firm, Ameli Global Partnerships (AGP), and participated with ACCP staff in professional development activities focused on DEI principles and best practices. In collaboration with AGP, ACCP’s initial Strategic Diversity, Equity, and Inclusion Plan was developed. Between 2021 and 2023 the majority of objectives in that plan were accomplished and additional member input was collected. Ongoing data and learning informed development of phase II action plans that appear in an updated DEIA plan that outlines objectives through 2025.

ACCP employs ongoing implementation and monitoring of the DEIA Plan. Access a comprehensive and routinely updated progress report here:

Diversity, Equity, Inclusion, and Accessibility Member Resources

The 2023 Task Force on DEIA developed a web-based toolkit for clinical pharmacists and trainees, highlighting ACCP’s commitment to build inclusive values into clinical pharmacy practice, education, and research initiatives. This dynamic online resource currently includes over 100 resources, is easily searchable, and is organized by topic, setting, and format.

Please contact members of the DEIA Task Force ([email protected]) with any recommended additions or revisions to the resources in the DEIA toolkit. The toolkit is intended to be a living resource.

Task Force on Diversity, Equity, Inclusion and Accessibility

The ACCP Task Force on Diversity, Equity, Inclusion, and Accessibility is empaneled each year to provide input and feedback to the ACCP Board of Regents on implementation of the DEIA plan and on all issues relevant to DEIA.

  • Deborah S. Bondi, Pharm.D., FCCP, BCPPS, BCPS - Chair
  • Kazuhiko Kido, Pharm.D., FCCP, BCCP, BCPS - Vice-Chair
  • Maha Abdalla, Pharm.D., Ph.D.
  • Sally Arif, Pharm.D., BCPS, BCCP
  • Deepali Bhandari, Pharm.D.
  • Jenna F. Cox, Pharm.D., BCPS, BCCCP
  • Mary F. Hebert, Pharm.D., FCCP
  • Rebecca Jayakumar, Pharm.D., BCIDP
  • Shayna Rae Killam, Pharm.D., MSDD
  • Lalita Prasad-Reddy, Pharm.D., MS, FCCP, BCACP, BCPS, CDE
  • Jordan Rowe, Pharm.D., BCACP, BC- ADM

Please contact the DEIA Task Force ([email protected]) with any questions or feedback on DEIA at ACCP.

Diversity, Equity, Inclusion, and Accessibility News

DEIA at the ACCP Annual Meeting
July 2024
Announcing New DEIA Travel Awards for Residents, Fellows, Graduate Students, and New Practitioners
June 2024
DEIA Task Force to Become a Standing Committee
June 2024
DEIA at ACCP: Call for Member Demographics
April 2024
Words Matter: Highlighting an Inclusive Language Resource in ACCP’s DEIA Toolkit
March 2024
DEIA at ACCP: A Focus on Elected Offices
February 2024
ACCP’s DEIA Progress Report
January 2024